UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage

Antimicrobial Agents and Chemotherapy, 2004-10, Vol.48 (10), p.3817-3822

2004

Volltextzugriff (PDF)

Novel Conserved Group A Streptococcal Proteins Identified by the Antigenome Technology as Vaccine Candidates for a Non-M Protein-Based Vaccine

Infection and Immunity, 2010-09, Vol.78 (9), p.4051-4067

2010

Volltextzugriff (PDF)

Identification of in vivo Expressed Vaccine Candidate Antigens from Staphylococcus aureus

Proceedings of the National Academy of Sciences - PNAS, 2002-05, Vol.99 (10), p.6573-6578

2002

Volltextzugriff (PDF)

Adjuvating the adjuvant: Facilitated delivery of an immunomodulatory oligonucleotide to TLR9 by a cationic antimicrobial peptide in dendritic cells

Vaccine, 2011-01, Vol.29 (3), p.426-436

2011

Volltextzugriff (PDF)

Helices α2 and α3 of West Nile Virus Capsid Protein Are Dispensable for Assembly of Infectious Virions

Journal of Virology, 2009-06, Vol.83 (11), p.5581-5591

2009

Volltextzugriff (PDF)

High-Affinity Binding of the Staphylococcal HarA Protein to Haptoglobin and Hemoglobin Involves a Domain with an Antiparallel Eight-Stranded β-Barrel Fold

Journal of Bacteriology, 2007-01, Vol.189 (1), p.254-264

2007

Volltextzugriff (PDF)

Chemokine degradation by the Group A streptococcal serine proteinase ScpC can be reconstituted in vitro and requires two separate domains

Biochemical journal, 2009-09, Vol.422 (3), p.533-542

2009

Volltextzugriff (PDF)

Innovating vaccines: From gene expression to translational entrepreneurship

Human vaccines, 2010-02, Vol.6 (2), p.164-168

von Gabain, Alexander

2010

Volltextzugriff (PDF)

In-Gel Analysis of Site-Specific RNases

BioTechniques, 2002-08, Vol.33 (2), p.272-276

2002

Volltextzugriff (PDF)

Functional Selection of Vaccine Candidate Peptides from Staphylococcus aureus Whole-Genome Expression Libraries In Vitro

Infection and Immunity, 2003-08, Vol.71 (8), p.4633-4641

2003

Volltextzugriff (PDF)

The Endoribonucleolytic N-Terminal Half of Escherichia coli RNase E Is Evolutionarily Conserved in Synechocystis sp. and Other Bacteria but Not the C-Terminal Half, Which Is Sufficient for Degradosome Assembly

Proceedings of the National Academy of Sciences - PNAS, 1998-09, Vol.95 (20), p.11637-11642

1998

Volltextzugriff (PDF)

Anti-infective antibodies: a novel tool to prevent and treat nosocomial diseases

Expert review of anti-infective therapy, 2008-02, Vol.6 (1), p.21-30

2008

Volltextzugriff (PDF)

Mammalian Hsp70 and Hsp110 Proteins Bind to RNA Motifs Involved in mRNA Stability

The Journal of biological chemistry, 1999-06, Vol.274 (24), p.17318-17324

1999

Volltextzugriff (PDF)

Host Factor I, Hfq, Binds to Escherichia coli ompA mRNA in a Growth Rate-Dependent Fashion and Regulates Its Stability

Proceedings of the National Academy of Sciences - PNAS, 1998-11, Vol.95 (24), p.14118-14123

1998

Volltextzugriff (PDF)

Selection of peptide entry motifs by bacterial surface display

Biochemical journal, 2002-10, Vol.367 (Pt 2), p.393-402

2002

Volltextzugriff (PDF)

Salmonella typhimurium and Lipopolysaccharide Stimulate Extracellularly Regulated Kinase Activation in Macrophages by a Mechanism Involving Phosphatidylinositol 3-Kinase and Phospholipase D as Novel Intermediates

Infection and Immunity, 1999-03, Vol.67 (3), p.1011-1017

1999

Volltextzugriff (PDF)

European biotech hasn't hit the street

EMBO reports, 2003-07, Vol.4 (7), p.642-646

2003

Volltextzugriff (PDF)

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies

The Journal of experimental medicine, 2008-01, Vol.205 (1), p.117-131

2008

Volltextzugriff (PDF)

Defined Synthetic Vaccines

Biological chemistry, 2001-04, Vol.382 (4), p.581-595

2001

Volltextzugriff (PDF)

Novel vaccines: Entrepreneurial contributions and scientific challenges

Vaccine, 2009-12, Vol.27, p.G1-G2

von Gabain, Alexander

2009

Volltextzugriff (PDF)

IC31® and IC30, novel types of vaccine adjuvant based on peptide delivery systems

Expert review of vaccines, 2007-10, Vol.6 (5), p.741-746

2007

Volltextzugriff (PDF)

Identification of a novel iron regulated staphylococcal surface protein with haptoglobin‐haemoglobin binding activity

Molecular microbiology, 2003-07, Vol.49 (1), p.37-53

2003

Volltextzugriff (PDF)

The novel adjuvant IC31® strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice

Vaccine, 2008-06, Vol.26 (27), p.3461-3468

2008

Volltextzugriff (PDF)

Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination

Vaccine, 2012-04, Vol.30 (19), p.2943-2950

2012

Volltextzugriff (PDF)

Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism

The Journal of clinical investigation, 2005-02, Vol.115 (2), p.468-475

2005

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(94)
Buchkapitel
(4)

Sprache

Englisch
(97)
Schwedisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(51)
Humans
(34)
Biological And Medical Sciences
(29)
Fundamental And Applied Biological Sciences. Psychology
(25)
Animals
(23)
Molecular Sequence Data
(22)
Base Sequence
(21)
Biochemistry & Molecular Biology
(21)
Microbiology
(21)
Rna, Messenger - Metabolism
(20)
Immunology
(18)
Escherichia Coli
(17)
Escherichia Coli - Genetics
(16)
Mice
(15)
Rna, Messenger - Genetics
(15)
Genes
(14)
Transcription, Genetic
(13)
Bacteriology
(12)
Medicine, Research & Experimental
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage

Novel Conserved Group A Streptococcal Proteins Identified by the Antigenome Technology as Vaccine Candidates for a Non-M Protein-Based Vaccine

Identification of in vivo Expressed Vaccine Candidate Antigens from Staphylococcus aureus

Adjuvating the adjuvant: Facilitated delivery of an immunomodulatory oligonucleotide to TLR9 by a cationic antimicrobial peptide in dendritic cells

Helices α2 and α3 of West Nile Virus Capsid Protein Are Dispensable for Assembly of Infectious Virions

High-Affinity Binding of the Staphylococcal HarA Protein to Haptoglobin and Hemoglobin Involves a Domain with an Antiparallel Eight-Stranded β-Barrel Fold

Chemokine degradation by the Group A streptococcal serine proteinase ScpC can be reconstituted in vitro and requires two separate domains

Innovating vaccines: From gene expression to translational entrepreneurship

In-Gel Analysis of Site-Specific RNases

Functional Selection of Vaccine Candidate Peptides from Staphylococcus aureus Whole-Genome Expression Libraries In Vitro

The Endoribonucleolytic N-Terminal Half of Escherichia coli RNase E Is Evolutionarily Conserved in Synechocystis sp. and Other Bacteria but Not the C-Terminal Half, Which Is Sufficient for Degradosome Assembly

Anti-infective antibodies: a novel tool to prevent and treat nosocomial diseases

Mammalian Hsp70 and Hsp110 Proteins Bind to RNA Motifs Involved in mRNA Stability

Host Factor I, Hfq, Binds to Escherichia coli ompA mRNA in a Growth Rate-Dependent Fashion and Regulates Its Stability

Selection of peptide entry motifs by bacterial surface display

Salmonella typhimurium and Lipopolysaccharide Stimulate Extracellularly Regulated Kinase Activation in Macrophages by a Mechanism Involving Phosphatidylinositol 3-Kinase and Phospholipase D as Novel Intermediates

European biotech hasn't hit the street

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies

Defined Synthetic Vaccines

Novel vaccines: Entrepreneurial contributions and scientific challenges

IC31® and IC30, novel types of vaccine adjuvant based on peptide delivery systems

Identification of a novel iron regulated staphylococcal surface protein with haptoglobin‐haemoglobin binding activity

The novel adjuvant IC31® strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice

Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination

Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism

Suchergebnisse filtern